Low levels of high-density lipoprotein (HDL), the so-called “good” cholesterol, are linked to more severe symptoms of systemic sclerosis (SSc)…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Activating TLR8, a viral defense mechanism involved in tissue fibrosis (scarring), primes monocytes isolated from the blood of people with…
The U.S. Food and Drug Administration (FDA) has granted orphan drug status to Aisa Pharma’s Profervia (cilnidipine), an investigational…
Higher circulating levels of a protein called thymic stromal lymphopoietin, or TSLP, may be linked to a greater risk of…
Long-term treatment with Volibris (ambrisentan), marketed as Letairis in the U.S., may help prevent mild pulmonary vascular disease from…
More than half of people with systemic sclerosis (SSc) who hesitated to get vaccinated against COVID-19 were concerned they…
June is awareness month for scleroderma, and this year’s theme chosen by the National Scleroderma Foundation is “Every…
Local injection with botulinum toxin type A (BTX-A), such as Botox, may ease the severity of pain associated with Raynaud’s…
People with more circulating cholesterol — a type of lipid (fat) that plays an important role in the body —…
In Italy, the prevalence of COVID-19 was greater, with the virus resulting in a higher death rate, among people with…